This compound is a protected amino acid derivative used as a building block in peptide synthesis. Its structure features a fluorenylmethoxycarbonyl (Fmoc) protecting group, a hydroxyl group, and a phenyl ring, contributing to its utility in constructing modified peptides.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1426128-64-4
Fmoc-3-Ala(2-thienyl)-OH
Peptide synthesis building block
H-Glu-OtBu.HCl
Peptide synthesis building block
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)triphenyl-L-methionine
Peptide synthesis building block
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-trityl-D-asparagine
Peptide synthesis building block
CARBAMIC ACID, N-[(1R)-2-[1,1'-BIPHENYL]-4-YL-1-(HYDROXYMETHYL)ETHYL]-, 1,1-DIMETHYLETHYL ESTER
Pharmaceutical intermediate for LCZ696
(R)-((2R,5R)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol
Pharmaceutical intermediate
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
Pharmaceutical intermediate for vericiguat synthesis
Ubrogepant Impurity 3
Pharmaceutical intermediate for ubrogepant synthesis
(2S,3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-hydroxy-4-phenylbutanoic acid
JZSULZSNDXGGHP-PKTZIBPZSA-N
C1=CC=C(C=C1)C[C@H]([C@@H](C(=O)O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24